MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- AJANTA PHARMA - TEVA PHARMA (Israel)
AJANTA PHARMA vs TEVA PHARMA (Israel) - Comparison Results
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 AJANTA PHARMA  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| AJANTA PHARMA Mar-19 |
TEVA PHARMA Dec-13 |
AJANTA PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 1,422 | 3,131 | - | |
| Low | Rs | 898 | 2,720 | - | |
| Sales per share (Unadj.) | Rs | 233.5 | 1,796.9 | - | |
| Earnings per share (Unadj.) | Rs | 44.0 | 112.2 | - | |
| Cash flow per share (Unadj.) | Rs | 52.2 | 257.5 | - | |
| Dividends per share (Unadj.) | Rs | 9.00 | 98.26 | - | |
| Dividend yield (eoy) | % | 0.8 | 3.4 | 23.1% | |
| Book value per share (Unadj.) | Rs | 255.1 | 1,996.0 | - | |
| Shares outstanding (eoy) | m | 88.02 | 848.00 | - | |
| Bonus/Rights/Conversions | BB | - | - | ||
| Price / Sales ratio | x | 5.0 | 1.6 | 305.1% | |
| Avg P/E ratio | x | 26.4 | 26.1 | 101.2% | |
| P/CF ratio (eoy) | x | 22.2 | 11.4 | 195.7% | |
| Price / Book Value ratio | x | 4.5 | 1.5 | 310.2% | |
| Dividend payout | % | 20.5 | 87.5 | 23.4% | |
| Avg Mkt Cap | Rs m | 102,081 | 2,480,731 | 4.1% | |
| No. of employees | `000 | 6.8 | 44.9 | 15.1% | |
| Total wages/salary | Rs m | 4,307 | 0 | - | |
| Avg. sales/employee | Rs Th | 3,022.6 | 33,902.6 | 8.9% | |
| Avg. wages/employee | Rs Th | 633.4 | 0 | - | |
| Avg. net profit/employee | Rs Th | 569.1 | 2,117.9 | 26.9% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 20,554 | 1,523,753 | 1.3% | |
| Other income | Rs m | 211 | 0 | - | |
| Total revenues | Rs m | 20,765 | 1,523,753 | 1.4% | |
| Gross profit | Rs m | 5,664 | 417,281 | 1.4% | |
| Depreciation | Rs m | 721 | 123,166 | 0.6% | |
| Interest | Rs m | 12 | 29,929 | 0.0% | |
| Profit before tax | Rs m | 5,143 | 264,185 | 1.9% | |
| Minority Interest | Rs m | 0 | 1,200 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | -173,423 | 0.0% | |
| Tax | Rs m | 1,273 | -3,225 | -39.5% | |
| Profit after tax | Rs m | 3,870 | 95,188 | 4.1% | |
| Gross profit margin | % | 27.6 | 27.4 | 100.6% | |
| Effective tax rate | % | 24.8 | -1.2 | -2,027.5% | |
| Net profit margin | % | 18.8 | 6.2 | 301.4% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 11,812 | 1,029,137 | 1.1% | |
| Current liabilities | Rs m | 3,776 | 897,495 | 0.4% | |
| Net working cap to sales | % | 39.1 | 8.6 | 452.5% | |
| Current ratio | x | 3.1 | 1.1 | 272.8% | |
| Inventory Days | Days | 77 | 91 | 85.2% | |
| Debtors Days | Days | 82 | 96 | 85.1% | |
| Net fixed assets | Rs m | 14,398 | 497,691 | 2.9% | |
| Share capital | Rs m | 175 | 3,751 | 4.7% | |
| Net worth | Rs m | 22,452 | 1,692,601 | 1.3% | |
| Long term debt | Rs m | 7 | 779,129 | 0.0% | |
| Total assets | Rs m | 26,962 | 3,482,264 | 0.8% | |
| Interest coverage | x | 444.3 | 9.8 | 4,521.6% | |
| Debt to equity ratio | x | 0 | 0.5 | 0.1% | |
| Sales to assets ratio | x | 0.8 | 0.4 | 174.2% | |
| Return on assets | % | 14.4 | 3.6 | 400.7% | |
| Return on equity | % | 17.2 | 5.6 | 306.5% | |
| Return on capital | % | 23.0 | 4.9 | 465.4% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 3,748 | 242,807 | 1.5% | |
| From Investments | Rs m | -2,228 | -86,036 | 2.6% | |
| From Financial Activity | Rs m | -1,475 | -291,264 | 0.5% | |
| Net Cashflow | Rs m | 45 | -134,493 | -0.0% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.01 Rs / USD
Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare AJANTA PHARMA With: SUN PHARMA NOVARTIS IPCA LABS STRIDES PHARMA SCIENCE VENUS REMEDIES
Today's Market
Infosys Q4FY21 Results, HDFC Bank to Raise Rs 500 Billion, and Buzzing Stocks Today(Pre-Open)
Indian share markets ended on a positive note yesterday, helped by gains in metals and banking stocks.
Related Views On News
AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)
Feb 5, 2021 | Updated on Feb 5, 2021For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.
AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)
Nov 6, 2020 | Updated on Nov 6, 2020For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.
AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)
Jun 24, 2019 | Updated on Jun 24, 2019Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.
More Views on NewsMost Popular
India: Recovery Stalled by Vaccine Games? (The Honest Truth)
Apr 13, 2021Ajit Dayal on how India's vaccine strategy will impact the markets.
4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)
Apr 6, 2021Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
An India Revival Stock I'm Bullish On... (Profit Hunter)
Apr 9, 2021This could take India to the position of 3rd largest economy.
Why Did the Market Crash on Monday? (Fast Profits Daily)
Apr 13, 2021In this video, I'll you what I think is the real reason behind yesterday's market crash.
Why the Market Fell Yesterday (Fast Profits Daily)
Apr 6, 2021In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.
More
